National Pharmaceutical Council Statement on Appointment of PCORI Board Chair

Washington, DC, September 19, 2013—The National Pharmaceutical Council (NPC) today released the following statement regarding the Government Accountability Office’s appointment of Dr. Grayson Norquist as chair of the Patient-Centered Outcomes Research Institute’s (PCORI) Board of Governors:

“We congratulate Dr. Norquist on his appointment as chair. He has been a thoughtful and active member of the PCORI board since its inception, and recognizes the importance of bringing all stakeholders into the conversation about the development and use of comparative effectiveness research in the United States,” said NPC President Dan Leonard.

“We stand ready to work with Dr. Norquist and continue the important stakeholder dialogue about comparative effectiveness research and its role in helping to improve health care outcomes,” added NPC Chief Science Officer Robert Dubois, MD, PhD.

About the National Pharmaceutical Council

The National Pharmaceutical Council is a health policy research organization dedicated to the advancement of good evidence and science, and to fostering an environment in the United States that supports medical innovation. Founded in 1953 and supported by the nation’s major research-based pharmaceutical companies, NPC focuses on research development, information dissemination, and education on the critical issues of evidence, innovation and the value of medicines for patients. For more information, visit www.npcnow.org.

# # #